UPSTREAM BIO, INC. (UPB) Market Cap
- 2026-09-03: Market Cap $334.1M.
- 2026-08-04: Market Cap $371.9M.
- 2026-06-30: Market Cap $379.02M.
- 2026-05-07: Market Cap $488.96M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2024-11-05 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $334.1M |
| 2026-08-04 | $371.9M |
| 2026-06-30 | $379.02M |
| 2026-05-07 | $488.96M |
| 2026-03-31 | $489.78M |
| 2026-03-20 | $471.82M |
| 2025-12-31 | $1.47B |
| 2025-11-03 | $1.35B |
| 2025-09-30 | $1.02B |
| 2025-08-04 | $841.53M |
| 2025-06-30 | $590.7M |
| 2025-05-02 | $464.78M |
| 2025-03-31 | $328.28M |
| 2025-03-05 | $454.34M |
| 2024-12-31 | $881.24M |
| 2024-11-05 | $1.47B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |